TIM-3 Expression and M2 Polarization of Macrophages in the TGFβ-Activated Tumor Microenvironment in Colorectal Cancer

M Katagata, H Okayama, S Nakajima, K Saito, T Sato… - Cancers, 2023 - mdpi.com
Simple Summary TGFβ and TIM-3 have been implicated in driving immune evasion and
poor response to anti-PD-1/PD-L1 immune checkpoint inhibitors (ICIs). Using large-scale …

Transcriptomic Profiling of Tumor-Infiltrating CD4+TIM-3+ T Cells Reveals Their Suppressive, Exhausted, and Metastatic Characteristics in Colorectal Cancer …

V Sasidharan Nair, SM Toor, RZ Taha, AA Ahmed… - Vaccines, 2020 - mdpi.com
T cell immunoglobulin mucin-3 (TIM-3) is an immune checkpoint identified as one of the key
players in regulating T-cell responses. Studies have shown that TIM-3 is upregulated in the …

Tim-3 promotes tumor-promoting M2 macrophage polarization by binding to STAT1 and suppressing the STAT1-miR-155 signaling axis

X Jiang, T Zhou, Y Xiao, J Yu, S Dou, G Chen… - …, 2016 - Taylor & Francis
ABSTRACT T cell Ig mucin-3 (Tim-3), an immune checkpoint inhibitor, shows therapeutic
potential. However, the molecular mechanism by which Tim-3 regulates immune responses …

Differential expression of TIM-3 in circulation and tumor microenvironment of colorectal cancer patients

S Khalaf, SM Toor, K Murshed, MA Kurer, AA Ahmed… - Clinical …, 2020 - Elsevier
T-cell immunoglobulin and mucin-domain containing-3 (TIM-3) is an inhibitory immune
checkpoint, which suppresses anti-tumor immune responses. TIM-3 expression on different …

TIM-3 Expression on Dendritic Cells in Colorectal Cancer

M Sakuma, M Katagata, H Okayama, S Nakajima… - Cancers, 2024 - mdpi.com
Simple Summary Since TIM-3 on T cells or dendritic cells (DCs) has recently emerged as an
attractive target for immunotherapy, we examined its expression on DCs using …

IL8 derived from macrophages inhibits CD8+ T-cell function by downregulating TIM3 expression through IL8-CXCR2 axis in patients with advanced colorectal cancer

C Zhao, D Wang, Z Li, Z Zhang, Y Xu, J Liu… - International …, 2023 - Elsevier
Background T cell immunoglobulin and mucin domain-containing protein 3 (TIM3) is a vital
immune checkpoint that regulates the immune response. However, the specific role of TIM3 …

[HTML][HTML] Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer

B Xu, L Yuan, Q Gao, P Yuan, P Zhao, H Yuan, H Fan… - Oncotarget, 2015 - ncbi.nlm.nih.gov
T-cell exhaustion represents a progressive loss of T-cell function. The inhibitory receptor PD-
1 is known to negatively regulate CD8+ T cell responses directed against tumor antigen, but …

[HTML][HTML] Spatial distribution and functional analysis define the action pathway of Tim-3/Tim-3 ligands in tumor development

T Wang, J Zhang, N Li, M Li, S Ma, S Tan, X Guo… - Molecular Therapy, 2022 - cell.com
The spatial organization of immune cells within the tumor microenvironment (TME) largely
determines the anti-tumor immunity and also highly predicts tumor progression and …

[HTML][HTML] Tim-3 finds its place in the cancer immunotherapy landscape

N Acharya, C Sabatos-Peyton… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
The blockade of immune checkpoint receptors has made great strides in the treatment of
major cancers, including melanoma, Hodgkin's lymphoma, renal, and lung cancer. However …

Modulation of the gut microbiota alters the tumour-suppressive efficacy of Tim-3 pathway blockade in a bacterial species-and host factor-dependent manner

B Lee, J Lee, MY Woo, MJ Lee, HJ Shin, K Kim, S Park - Microorganisms, 2020 - mdpi.com
T cell immunoglobulin and mucin domain-containing protein-3 (Tim-3) is an immune
checkpoint molecule and a target for anti-cancer therapy. In this study, we examined …